Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 294
Selected: 0
NCT IDTitle
NCT06295757Effects of Relighting on Smoke Toxicant Deliveries and Subjective Smoking Measures
NCT05634512Evaluation of Intravenous Laronidase Pharmacokinetics Before and After Hematopoietic Cell Transplantation in Patients With Mucopolysaccharidosis Type IH.
NCT00478244Allogeneic Hematopoietic Stem Cell Transplant For Epidermolysis Bullosa
NCT00609739Cytosine Arabinoside and Mitoxantrone for Patients With Juvenile Myelomonocytic Leukemia Receiving Repeat Stem Cell Transplantation
NCT03674411Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy
NCT00331422Carboplatin, Paclitaxel, and Surgery in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer
NCT01560923Phase II Study of Sipuleucel-T and Indoximod for Patients With Refractory Metastatic Prostate Cancer
NCT01343368Preservation of Ovarian Function After Hematopoietic Cell Transplant
NCT01634217Inducible Regulatory T Cells (iTregs) in Non-Myeloablative Sibling Donor Peripheral Blood Stem Cell Transplantation
NCT03019666Ph I Trial of NAM NK Cells and IL-2 for Adult Pts With MM and NHL
NCT00748163Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Sunitinib as First-Line Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer
NCT01288222Selecting a Favorable KIR Donor in Unrelated HCT for AML
NCT00281827Carboplatin, Gemcitabine, and Thalidomide in Patients Undergoing Surgery for Stage II or III Non-Small Cell Lung Cancer
NCT03367546Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation (HaploHCT) Following Reduced Intensity Conditioning (RIC) for Selected High Risk Non-Malignant Diseases
NCT00686556Total Marrow Irradiation for Refractory Acute Leukemia
NCT00177047Autologous Transplant for Multiple Myeloma
NCT00352118Combination Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer
NCT00309842Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases
NCT02171104MT2013-31: Allo HCT for Metabolic Disorders and Severe Osteopetrosis
NCT01173016Administration of IV Laronidase Post Bone Marrow Transplant in Hurler
NCT06322992App-Assisted Day Reconstruction to Reduce Treatment Burden and Logistic Toxicity in Cancer Patients - Aim 3
NCT04204772A Pilot Feasibility Study of Activated Charcoal in Healthy Volunteers
NCT00855114Everolimus in Treating Women With Breast Cancer That Can Be Removed by Surgery
NCT03557749Monitoring of Immune and Microbial Reconstitution in (HCT) and Novel Immunotherapies
NCT01033552Biochemical Correction of Severe EB by Allo HSCT and "Off-the-shelf" MSCs
NCT00618696Yttrium Y 90 Anti-CD45 Monoclonal Antibody AHN-12 in Treating Patients With Advanced Leukemia
NCT00432094Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors
NCT00295880Donor Umbilical Cord Blood Transplant By Injection Into the Bone Marrow in Treating Patients With Hematologic Cancer
NCT00619021Bronchial Artery Infusion of Gemcitabine in Treating Patients With Recurrent or Progressive Non-Small Cell Lung Cancer
NCT03687073Trial of Indole-3-Carbinol and Silibinin
NCT01099631IL-2 Expressing, Attenuated Salmonella Typhimurium in Unresectable Hepatic Spread
NCT00769990Genistein in Treating Patients Undergoing External-Beam Radiation Therapy for Bone Metastases
NCT03789721Adrenoleukodystrophy National Registry Study
NCT05643014Observational Study of Exposure to Environmental Toxicants Among Firefighters
NCT04514471Feasibility Study - Filter Ventilation
NCT00167180Post Transplant Donor Lymphocyte Infusion
NCT00602446Deferasirox in Treating Patients With Iron Overload After Undergoing a Donor Stem Cell Transplant
NCT03314974Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
NCT00290628Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer
NCT03213964Intraperitoneal Delivery of Adaptive Natural Killer (NK) Cells (FATE-NK100) With Intraperitoneal Int
NCT02118311Treg Cells for AGVHD in Non-myeloablative UCB Transplant
NCT00369291CpG 7909 in Treating Patients Who Have Undergone Autologous Stem Cell Transplant
NCT00725062Donor T Cells in Treating Patients With High-Risk Hematologic Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant
NCT00258362Carboplatin, Docetaxel, and Radiation Therapy in Treating Patients With Stage III/IV, or Recurrent Endometrial Cancer
NCT02156674Naglazyme After Allo Transplant for Maroteaux-Lamy Syndrome
NCT00630565Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia
NCT00610740CerviPrep for Applying Topical Gemcitabine to the Cervix in Treating Patients With Primary Endometrial, Cervical, or Ovarian Epithelial Cancer
NCT00703638Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors
NCT07493538MT2025-35 Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning Treosulfan and Fludarabine, With Post-Transplant Cytoxan (PTCy) for the Treatment of Hematological Diseases
NCT00888316Iron Overload in Patients Undergoing Donor Stem Cell Transplant